described a mucinsplitting enzyme in cultures of Vibrio comma which causes desquamation of the intestinal mucosa of guinea pigs and have suggested a role for this mucinase in the pathogenesis of Asiatic cholera. While possession of this enzyme may be an important factor in determining the virulence of cholera strains, it is by no means the only attribute, since avirulent vibrio cultures also elaborate it (Singh and Ahuja, 1953; Freter, 1955) . Nevertheless the addition of this material to cholera vaccine is being considered (Lowenthal, 1956) , and studies have indicated that at least two distinct serological types of the enzyme designated types A and B, are elaborated by cholera cultures (Freter, 1955) .
In view of the similarity of some of the clinical manifestations of cholera and bacillary dysentery, cultures representing the various serotypes of Shigella were screened for mucinolytic activity. It was found that of the strains tested only those of Shigella flexneri strains 2a, X, and Y produced demonstrable amounts of mucinase (Formal and Lowenthal, 1956 (Formal and Lowenthal, 1956) . For antiserum production, rabbits were immunized with concentrated enzyme preparations. In the case of the flexner and coli mucinases, the concentration was accomplished either by lyophilization or by precipitation at 4 C with 60 per cent (by volume) acetone of the crude supernatant and resuspending the resulting solid material in one tenth its original volume. The cholera mucinases were concentrated using ammonium sulfate precipitation as described by Lowenthal (1956) .
Antisera. Antimucinase sera were prepared by inoculating rabbits at first subcutaneously and then intravenously with the tenfold concentrated mucinase preparations. Usually 8 to 10 injections of 0.5 to 1.0 ml were sufficient to evoke a satisfactory response. This response was estimated by employing the constant antigen-varying antibody technique previously described (Formal and Lowenthal, 1956) .
Titrations. In vitro mucinolytic activity was measured by the ability of the mucinase to depolymerize ovomucin so that the latter is no longer precipitable by cetyl trimethylammonium bromide (CTAB) (Formal and Lowenthal, 1956 ). The ovomucin was prepared by the method of Gottschalk and Lind (1949) and was standardized by the addition of borate-buffered, calcium saline, pH 7.0, so that a further 1:2 dilution of the ovomucin formed a precipitate on the addition of CTAB while a 1:4 dilution did not. A single preparation of ovomucin was employed in this study.
For routine mucinase-inhibition tests the variable antigen-constant antibody procedure was employed (Freter, 1955) . Twofold serial dilutions of the mucinase preparations were made in borate buffered saline in final volumes of 0.25 ml. To these was added 0.25 ml of 1.25 per cent normal or immune serum. After incubation at room temperature for 112 hr, 0.5 ml ovomucin was added and the tubes incubated for 30 min at 40 C. At this time a drop of 0.1 per cent CTAB was added to each tube and the highest dilution which remained free of precipitate was taken as the mucinase titer.
RESULTS
The ability of the various antimucinase sera used in this study to inhibit the activity of their homologous mucinase preparations was deter-467 FORMAL, LOWENTHAL, AND GALINI)O (Freter, 1955 A strain of Escherichia coli belonging to group 017 has been described which is mucinase positive.
The mucinases from strains of S. flexneri are not serologically related to those produced by E. coli or Vibrio comma.
